🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

RecruitingNAAges 18 Years - anyAllBoston Medical Center
NCT06732596 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of Opioid Use Disorder (OUD) * Within 30 days of intake at recruitment site (BMC OBAT) * Possession of a smartphone that has minimum requirements * English-speaking and reading * Willing to release electronic health record (EHR) data * Able to provide at least two alternate contacts who usually know how to get in touch with them * Currently prescribed buprenorphine from an outpatient clinic Exclusion Criteria: * Incarceration anticipated within 12 months of enrollment * Inability to comprehend the study protocol, defined as failing three times to answer correctly a set of questions during the consent process * Inability to use the ECA app (i.e., due to markedly limited visual or auditory acuity or motor function required to interact with the ECA)
💊

What it tests

  • Embodied conversational agent (ECA)
  • Technical support
  • Additional ECA messages
  • Additional incentives
📍

Where

1 site
Office-Based Addiction Treatment (OBAT) Clinic, BMC
Boston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy